Τετάρτη 18 Ιανουαρίου 2017

New drug in development shows improved progression-free survival for patients with advanced metastatic midgut neuroendocrine tumors

A new therapy in development for the treatment of midgut neuroendocrine tumours, a rare type of cancer that occurs in the small intestine and colon, shows improved progression-free survival and response rates for patients with advanced disease. Results...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jKhsaL
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις